In a filing, Bio-Techne Corp revealed its Director KIM KELDERMAN acquired Company’s shares for reported $1.03 million on Jan 27 ’25. In the deal valued at $77.05 per share,13,392 shares were bought.
Then, BAUMGARTNER ROBERT V sold 16,000 shares, generating $1,153,664 in total proceeds. Upon selling the shares at $72.10, the Director now owns 43,401 shares.
Before that, ROBERT V. BAUMGARTNER bought 16,000 shares. Bio-Techne Corp shares valued at $1,153,664 were divested by the Director at a price of $72.10 per share.
Citigroup downgraded its Bio-Techne Corp [TECH] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early February with a ‘”a Sector outperform”‘ rating. Stifel also remained covering TECH and has decreased its forecast on February 02, 2024 with a “Hold” recommendation from previously “Buy” rating. UBS started covering the stock on December 07, 2023. It rated TECH as “a Buy”.
Price Performance Review of TECH
On Tuesday, Bio-Techne Corp [NASDAQ:TECH] saw its stock fall -2.42% to $74.60. Over the last five days, the stock has lost -5.27%. Bio-Techne Corp shares have risen nearly 3.57% since the year began. Nevertheless, the stocks have risen 4.89% over the past one year. While a 52-week high of $85.57 was reached on 01/22/25, a 52-week low of $61.16 was recorded on 01/03/25. SMA at 50 days reached $74.13, while 200 days put it at $74.40.
Levels Of Support And Resistance For TECH Stock
The 24-hour chart illustrates a support level at 72.95, which if violated will result in even more drops to 71.30. On the upside, there is a resistance level at 76.86. A further resistance level may holdings at 79.12. The Relative Strength Index (RSI) on the 14-day chart is 47.72, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 68.60%. Stochastics %K at 55.27% indicates the stock is a holding.
How much short interest is there in Bio-Techne Corp?
A steep rise in short interest was recorded in Bio-Techne Corp stocks on 2025-01-15, growing by 0.54 million shares to a total of 4.05 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 3.51 million shares. There was a rise of 13.38%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 28, 2023 when William Blair began covering the stock and recommended ‘”an Outperform”‘ rating .
